Jianxin Medical Sweeps Championship and Runner-up Titles at the 6th China Medical Device Innovation and Entrepreneurship Competition with Groundbreaking Products

Twin Blooms, Radiant Success! On May 25, at the 6th (2023) China Medical Device Innovation and Entrepreneurship Competition, Qingdao Jianxin Medical Technology Co., Ltd. (hereinafter referred to as “Jianxin Medical”) competed with nearly 100 outstanding projects from across China, presenting two products: “R&D of an Intelligent Dual-Engine Dynamic Hybrid Energy Surgical System” and “R&D and Industrialization of an Ultrasonic Lithotripsy System for Ureteral Stones.” Ultimately, they secured the championship and runner-up positions with high scores of 88.31 and 85.66, respectively, sweeping all first-prize awards in the diagnostic and therapeutic equipment category and emerging as the biggest winner of the competition!

The two award-winning projects from Jianxin Medical are both innovative products independently developed by the company, featuring core technologies and patents. This fully demonstrates Jianxin Medical’s independent R&D capabilities and exceptional innovation strength.

Competition Venue (Swipe left or right to view more)

A global first, this innovation is applicable to diverse clinical scenarios and resolves, for the first time, the scientific challenge of dynamically blending two energy outputs based on tissue characteristics. It not only fills a domestic gap but also pioneers the next generation of energy-based surgical devices, marking Jianxin Medical’s achievement of genuine Chinese originality in minimally invasive surgery and enabling domestically produced medical devices to “overtake on the straightaway.” The project has been successfully approved as a special initiative under the Ministry of Science and Technology’s National Key R&D Program and has entered the National Medical Products Administration’s (NMPA) priority review green channel, with NMPA registration and market launch expected by mid-2024.

A globally first-of-its-kind dual-frequency ultrasonic lithotripsy system designed for ureteral stones with no thermal injury, featuring internationally leading advantages such as low thermal damage, intelligent identification of stone characteristics, and dynamic control of ultrasonic energy output. The ultrasonic energy conversion and emission device and the ultrasonic waveguide rod are both original designs, enabling superior clinical outcomes. This system is currently the only full urinary tract lithotripsy system worldwide; the prototype has been completed and is about to undergo registration testing.

As an innovative medical device R&D company with core foundational technologies, Jianxin Medical has consistently adhered to driving clinical transformation through innovation and guiding product development by addressing clinical pain points. By developing a series of therapeutic devices and building a visualized surgical platform, the company has established a complete closed-loop clinical application integrating minimally invasive surgical diagnosis and treatment, achieving genuine Chinese originality in the field of minimally invasive surgery and enabling Chinese medical devices to “overtake on the straightaway.”

The first anti-adhesion ultrasonic energy system for 5mm vessel cutting and hemostasis has obtained the NMPA Class III product registration certificate, has been applied in multiple domestic surgical robots, and its technology has been licensed by internationally renowned companies.

The world’s first original, dual-probe 3D ultrasound system, which simultaneously addresses “temporal precision” and “spatial localization accuracy,” has completed its prototype and is about to undergo regulatory testing. By providing physicians with “two” fluoroscopic eyes, this product effectively resolves the limitation of conventional ultrasound imaging—where only two-dimensional images are available—thereby enabling real-time, precise localization of lesions within a three-dimensional spatial coordinate system.

Company Honors (Swipe left or right to view more)

Enhancing clinical value to achieve both social and economic benefits is a fundamental requirement for innovative products. Jianxin Medical’s sustained innovation momentum stems from its precise analysis of clinical pain points and targeted technological breakthroughs. The company continuously explores innovative R&D in specialized segments of the medical device industry, leveraging patent big data, macro-level data analysis, and micro-level product navigation to foster the development of innovative solutions and build a clinical-pain-point-driven product innovation system.

Anchored in source innovation, Jianxin Medical conducted a structured analysis of 170,000 clinical medical device patents held by physicians. Through processes including screening, indexing, and analysis, the company generated statistical results on patent trends related to clinical pain points, areas of clinical interest, and technological development trajectories. It completed original analytical reports in fields such as stomatology, urology, orthopedics, and thoracic surgery, pioneering globally the first physician pain point-centric patent analysis model, which serves as the foundation for its product innovation initiatives.

Jianxin Medical boasts a professional R&D team spanning multiple disciplines, including acoustics, optics, electronics, and mechanics. The company possesses comprehensive original technologies across various fields such as energy-based devices, imaging, and non-invasive therapies, and has established a robust system for the translation of innovative achievements into practical applications. It has built several specialized R&D platforms, including those for real-time imaging technology, acoustic and electrical energy technology, ultrasound therapy technology, and materials and process technology. In the domains of minimally invasive surgical equipment and visualized surgical platforms, Jianxin Medical has filed over 80 patent applications, with invention patents accounting for more than 40% of the total.

The company has also partnered with the China Technology Exchange, the Liaoning Provincial Medical Device Inspection and Testing Institute under the National Medical Products Administration (NMPA), Qingdao Innovation Investment Co., Ltd., and Kunshan Kesen Technology Co., Ltd. to establish the Medical Device Industry Innovation Research Institute. This institute facilitates coordinated development across key value chains—including intellectual property commercialization, product technology development, specialized technical services, full-lifecycle product incubation, and investment and financing services—thereby driving industrial growth and product innovation.

“Achieving Leapfrog Development in the Medical Device Industry Through Original Chinese Innovation” is the goal and mission of Jianxin Medical! The company will consistently adhere to source innovation, continuously improve the system for converting innovative achievements into practical applications, and truly lead the development of minimally invasive surgical treatment equipment and visualized surgical systems with its fully original minimally invasive surgical products and robust core foundational technologies.

As part of the “Science and Technology Innovation China” series, the China Medical Device Innovation and Entrepreneurship Competition was initiated and guided by the Department of Social Development Science and Technology of the Ministry of Science and Technology and the China National Center for Biotechnology Development, and organized by the Strategic Alliance for Technological Innovation in the Medical Device Industry. It stands as the most authoritative professional competition in the medical device sector, boasting the most distinguished panel of judges and the highest quality of participating projects. Adhering to the principles of “standardization, rigor, and evidence-based practice,” the two-day event featured nearly 100 innovative projects competing side by side, showcasing cutting-edge achievements in the field of innovative medical devices. Nearly 100 senior industry experts from research institutes, investment and financing institutions, and innovation service organizations, along with leaders from leading domestic and international medical device enterprises, gathered to jointly discuss technological innovations in the medical device sector.